Skleroteraapiat

Skleroteraapiat is a minimally invasive medical procedure used primarily to treat varicose veins and other venous insufficiencies. The technique involves the injection of a sclerosant solution into problematic veins, causing them to collapse and eventually fade from view. This process redirects blood flow to healthier veins, alleviating symptoms such as swelling, pain, and cosmetic concerns related to varicose veins.

The procedure is performed under ultrasound guidance to ensure precise delivery of the sclerosant. Common sclerosant agents include sodium tetradecyl sulfate and polidocanol, which irritate the inner lining of the affected veins. The resulting inflammation prompts fibrosis and closure of the vein. Skleroteraapiat is typically conducted on an outpatient basis, often requiring only local anesthesia, and usually takes less than an hour.

Skleroteraapiat is considered safe and effective, with a high success rate in reducing venous symptoms and improving appearance. Possible side effects include local skin irritation, allergic reactions, or inflammation of nearby tissues. Rarely, pigmentation or blood clots may occur, necessitating further medical attention.

This treatment option is suitable for patients with superficial varicose veins and is often used as an alternative or complement to surgical procedures like vein stripping. Post-treatment, patients are usually advised to wear compression stockings and to engage in regular physical activity to support vein healing and prevent recurrence.

Skleroteraapiat represents a significant advancement in vascular therapy, offering a treatment approach that minimizes discomfort and downtime while providing effective symptom relief. Its use continues to evolve with ongoing research aimed at enhancing safety and efficacy.